Table 1.
The relationship between PAQR4 gene expression and the prognosis of different cancers in PrognoScan.
| Dataset | Cancer type | ENDPOINT | Probe ID | Corrected P value | In (HR high/HR low) | COX P value | In (HR) | 95% CI | Reference | |
|---|---|---|---|---|---|---|---|---|---|---|
| A | GSE4922 | Breast cancer | Disease-free survival | 212858_at | 0.001079 | 0.96 | 0.002088 | 0.57 | 1.76 (1.23-2.52) | PMID: 17079448 |
| B | GSE17710 | Lung cancer | Overall survival | 27382 | 0.001399 | 1.42 | 0.011716 | 0.56 | 1.75 (1.13-2.69) | PMID: 20643781 |
| C | GSE16581 | Brain cancer | Overall survival | 212858_at | 0.023357 | 2.08 | 0.143075 | 2.67 | 14.46 (0.40-516.58) | PMID: 20015288 |
| D | GSE13507 | Bladder cancer | Overall survival | ILMN_1660793 | 0.002041 | 0.97 | 0.000628 | 0.43 | 1.54 (1.20-1.98) | PMID: 20059769 |
| E | GSE31210 | Lung cancer | Relapse-free survival | 212858_at | 0.006116 | 1.02 | 0.008767 | 0.88 | 2.40 (1.25-4.63) | PMID: 22080568 |
| F | GSE1456 | Breast cancer | Relapse-free survival | 212858_at | 0.015712 | 1.06 | 0.009348 | 0.83 | 2.30 (1.23-4.32) | PMID: 16813654 |
| G | GSE30929 | Soft tissue cancer | Distant recurrence free survival | 212858_at | 0.017279 | 0.99 | 0.00357 | 1.49 | 4.46 (1.63-12.18) | PMID: 21335544 |
| H | GSE3494 | Breast cancer | Disease-specific survival | 212858_at | 0.035271 | 1.10 | 0.003606 | 0.68 | 1.98 (1.25-3.12) | PMID: 16141321 |
| I | GSE13507 | Bladder cancer | Disease-specific survival | ILMN_1660793 | 0.011424 | 1.27 | 0.000679 | 0.63 | 1.88 (1.30-2.69) | PMID: 20059769 |